ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer - European Society for Medical Oncology (ESMO)

• This special article provides updated treatment recommendations on thyroid cancer.

• New targeted systemic therapies have now been approved for treating patients with advanced/metastatic thyroid cancers.

• This article summarises these new options and the order in which they should be used.

• Recommendations are based on available scientific data and the authors’ collective expert opinion.

• ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.

• Authorship includes a multidisciplinary group of thyroid cancer experts.


Read full Guideline